Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
Helgadottir, Hildur, Ny, Lars, Ullenhag, Gustav J, Falkenius, Johan, Mikiver, Rasmus, Olofsson Bagge, Roger, Isaksson, Karolin
Published in JNCI : Journal of the National Cancer Institute (2023)
Published in JNCI : Journal of the National Cancer Institute (2023)
Get full text
Journal Article
Safety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
Mau-Sorensen, M., van Bussel, M., Kuipers, M., Nielsen, D.L., Verheul, H.M., Aftimos, P., de Jonge, M.J.A., van Triest, B., Falkenius, J., Debus, J., Troost, E., Samuels, M., Sarholz, B., Budach, V., Goel, S., Locatelli, G., Geertsen, P.F.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A gene expression profile associated with clinical outcome in stage III melanoma
Falkenius, J., Lindberg, J., Johansson, H., Frostvik-Stolt, M., Lundeberg, J., Hansson, J., Egyhazi, S.
Published in JOURNAL OF CLINICAL ONCOLOGY (2011)
Published in JOURNAL OF CLINICAL ONCOLOGY (2011)
Get full text
Journal Article
Conference Proceeding
1079MO Survival before and after the introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study
Helgadottir, H., Ny, L., Ullenhag, G.J., Falkenius, J., Mikiver, R., Olofsson Bagge, R., Isaksson, K.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
Overall survival after the introduction of adjuvant treatment in stage III melanoma: A nationwide registry based study
Helgadottir, Hildur, Ny, Lars, Ullenhag, Gustav J., Falkenius, Johan, Mikiver, Rasmus, Olofsson Bagge, Roger, Isaksson, Karolin
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Published in JOURNAL OF CLINICAL ONCOLOGY (01.06.2023)
Get full text
Journal Article
Conference Proceeding
Precision radiation of immune checkpoint therapy resistant melanoma metastases (PROMMEL study): study protocol for a phase II open-label multicenter trial
Backlund, Ellen, Yang, Muyi, Grozman, Vitali, Masucci, Giuseppe, Falkenius, Johan, Eriksson, Hanna, Jovanovic, Braslav, Hammarlund, Katarina, Isacsson, Ulf, Radu, Calin, Abel, Edvard, Karlsson, Kristin, Palanco Zamora, Ricardo, Wersäll, Peter, Edbäck, Ulrika, Wickström, Stina, Darai Ramqvist, Eva, Egyhazi Brage, Suzanne, Kiessling, Rolf, Viktorsson, Kristina, Franzén, Bo, Lewensohn, Rolf, Olofsson Bagge, Roger, Ullenhag, Gustav J., Ny, Lars, Lindberg, Karin, Helgadottir, Hildur
Published in Acta oncologica (2022)
Published in Acta oncologica (2022)
Get full text
Journal Article
1845PSafety, clinical activity and pharmacological biomarker evaluation of the DNA-dependent protein kinase (DNA-PK) inhibitor M3814: Results from two phase I trials
Mau-Sorensen, M, van Bussel, M, Kuipers, M, Nielsen, D L, Verheul, H M, Aftimos, P, de Jonge, M J A, van Triest, B, Falkenius, J, Debus, J, Troost, E, Samuels, M, Sarholz, B, Budach, V, Goel, S, Locatelli, G, Geertsen, P F
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
A phase Ia/Ib trial of the DNA-PK inhibitor M3814 in combination with radiotherapy (RT) in patients (pts) with advanced solid tumors: Dose-escalation results
Van Triest, Baukelien, Damstrup, Lars, Falkenius, Johan, Budach, Volker, Troost, Esther, Samuels, Michael, Debus, Juergen, Sørensen, Morten Mau, Berghoff, Karin, Strotman, Rainer, van Bussel, Mark, Goel, Sanjay, Geertsen, Poul F.
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2018)
Published in JOURNAL OF CLINICAL ONCOLOGY (20.05.2018)
Get full text
Journal Article
Conference Proceeding
Presence of immune cells, low tumor proliferation and wild type BRAF mutation status is associated with a favourable clinical outcome in stage III cutaneous melanoma
Falkenius, Johan, Johansson, Hemming, Tuominen, Rainer, Frostvik Stolt, Marianne, Hansson, Johan, Egyhazi Brage, Suzanne
Published in BMC cancer (29.08.2017)
Published in BMC cancer (29.08.2017)
Get full text
Journal Article
Overview of immune-related side effects from immune checkpoint inhibitors. Part 2: Endocrine, rheumatologic and skin toxicity
Helgadottir, Hildur, Falkenius, Johan, Eriksson, Hanna, Girnita, Ada, Sahlberg, Liselott, Bensing, Sophie, Chatzidionysiou, Katerina, Masucci, Giuseppe, Ullenhag, Gustav
Published in Läkartidningen (18.11.2021)
Get more information
Published in Läkartidningen (18.11.2021)
Journal Article
High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma
Falkenius, Johan, Lundeberg, Joakim, Johansson, Hemming, Tuominen, Rainer, Frostvik-Stolt, Marianne, Hansson, Johan, Egyhazi Brage, Suzanne
Published in Melanoma research (01.12.2013)
Published in Melanoma research (01.12.2013)
Get more information
Journal Article
Surgical treatment of skeletal metastases in 31 melanoma patients
Wedin, Rikard, Falkenius, Johan, Weiss, Rüdiger J, Hansson, Johan
Published in Acta orthopaedica belgica (01.04.2012)
Get full text
Published in Acta orthopaedica belgica (01.04.2012)
Journal Article